Cerus (CERS) has issued an update.
Dean Gregory, previously President of Global Commercial Operations at Med Tech for Fresenius Kabi, has accepted an invitation to join the Board of Directors at Cerus Corporation. Set to serve until the 2027 annual stockholders’ meeting, he will receive a $45,000 annual cash retainer, paid quarterly, and an initial restricted stock unit award for 60,000 shares, vesting over three years. Additionally, Gregory will be eligible for an annual stock award based on the company’s stock price, subject to continuous service, and will be fully vested in the event of a company takeover. He will also benefit from the company’s standard indemnity agreement for directors and officers.
For an in-depth examination of CERS stock, go to TipRanks’ Stock Analysis page.
